(Reuters) -CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would shift to fixed rates for reimbursements from pharmacy benefit managers and insurers, to boost transparency amid scrutiny on high drug prices. Out-of-pocket drug prices in the U.S. are decided by a complex, multi-tiered network including insurers, drugmakers, pharmacies and pharmacy benefit managers (PBMs), resulting in ambiguity around fees and markups to the original cost of the drug. The new CVS mod
CVS Health revamps pharmacy reimbursement model fiercehealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercehealthcare.com Daily Mail and Mail on Sunday newspapers.
Forbes has released its annual list of the 100 most powerful women in the world, including Taylor Swift, Rihanna and Barbie. Four U.S.-based women in healthcare